Libtayo available in Scotland for cervical cancer patients - PharmaTimes New immunotherapy offers hope for recurrent cervical cancer

#oncology #womenshealth #Libtayo #cemiplimab #NHSScotland #cervicalcancer #immunotherapy #Regeneron #ScottishMedicinesConsortium #SMCacceptance #SMC #metastaticcervicalcancer #humanmonoclonalantibody #immunecheckpointreceptor #EMPOWERCervical1phase3trial
pharmatimes.com/news/libtayo...